Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bert Bammens

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|July 23, 2013
Aortic calcifications and arterial stiffness as predictors of cardiovascular events in incident renal transplant recipientsKathleen J Claes, Sam Heye, Bert Bammens, et al.
Acta Cardiologica|March 6, 2013
Survival and heart failure therapy in chronic dialysis patients with heart failure and reduced left ventricular ejection fraction: an observational retrospective studyDavid Derthoo, Ann Belmans, Kathleen Claes, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2008
Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantationPieter Evenepoel, Bjorn K I Meijers, Hylke de Jonge, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 6, 2009
Calcium metabolism in the early posttransplantation periodPieter Evenepoel, Barbara Van Den Bergh, Maarten Naesens, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 11, 2013
Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcomeThomas Vanhove, Dirk Kuypers, Kathleen J Claes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 20, 2018
Natural history of mineral metabolism, bone turnover and bone mineral density in de novo renal transplant recipients treated with a steroid minimization immunosuppressive protocolPieter Evenepoel, Kathleen Claes, Björn Meijers, et al.
Toxins|May 31, 2020
Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug-Bug Interaction?Lu Dai, Björn K Meijers, Bert Bammens, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 15, 2018
Poor Vitamin K Status Is Associated With Low Bone Mineral Density and Increased Fracture Risk in End-Stage Renal DiseasePieter Evenepoel, Kathleen Claes, Bjorn Meijers, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 3, 2009
Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trialJohan Scharpé, Willy E Peetermans, Johan Vanwalleghem, et al.
Clinical Kidney Journal|August 4, 2021
Strategies for asymmetrical triacetate dialyser heparin-free effective haemodialysis: the SAFE studyInes Vandenbosch, Sander Dejongh, Kathleen Claes, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Transplant International : Official Journal of the European Society for Organ Transplantation|July 23, 2013
Aortic calcifications and arterial stiffness as predictors of cardiovascular events in incident renal transplant recipientsKathleen J Claes, Sam Heye, Bert Bammens, et al.
Acta Cardiologica|March 6, 2013
Survival and heart failure therapy in chronic dialysis patients with heart failure and reduced left ventricular ejection fraction: an observational retrospective studyDavid Derthoo, Ann Belmans, Kathleen Claes, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2008
Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantationPieter Evenepoel, Bjorn K I Meijers, Hylke de Jonge, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 6, 2009
Calcium metabolism in the early posttransplantation periodPieter Evenepoel, Barbara Van Den Bergh, Maarten Naesens, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 11, 2013
Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcomeThomas Vanhove, Dirk Kuypers, Kathleen J Claes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 20, 2018
Natural history of mineral metabolism, bone turnover and bone mineral density in de novo renal transplant recipients treated with a steroid minimization immunosuppressive protocolPieter Evenepoel, Kathleen Claes, Björn Meijers, et al.
Toxins|May 31, 2020
Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug-Bug Interaction?Lu Dai, Björn K Meijers, Bert Bammens, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 15, 2018
Poor Vitamin K Status Is Associated With Low Bone Mineral Density and Increased Fracture Risk in End-Stage Renal DiseasePieter Evenepoel, Kathleen Claes, Bjorn Meijers, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 3, 2009
Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trialJohan Scharpé, Willy E Peetermans, Johan Vanwalleghem, et al.
Clinical Kidney Journal|August 4, 2021
Strategies for asymmetrical triacetate dialyser heparin-free effective haemodialysis: the SAFE studyInes Vandenbosch, Sander Dejongh, Kathleen Claes, et al.
Pageof 10